Select Page
FDA Grants Memgen IND Application Clearance

FDA Grants Memgen IND Application Clearance

The US FDA (Food and Drug Administration) has granted IND (investigational new drug) application clearance for Memgen’s MEM-288, their cancer immunotherapy treatment for patients with multiple solid tumors. Following this announcement, Memgen, a clinical-stage...